News

Finnish healthtech startup NADMED brings to market a new type of NAD metabolite measurement. After years of rigorous studies at University of Helsinki, NADMED presents a first-of-a-kind solution which allows more profound and faster study of NADs. In...

Knowledge work of today is all about creative problem-solving – but we are having difficulty finding the mental space for focus and flow. Studies show that creativity narrows down under pressure, while stress prevents presence and proper rest....

New Finnish digital health company Hoivita aims to ease nurse shortage in elderly careTwo Finnish, Lappeenranta-based startups Henkaus and Vesratio, have announced their merger, creating a new digital health company Hoivita that aims to improve the...

Finnish health tech startup Sonai Health Oy is looking to bring special care diagnostics into primary care in a big way. Sonai is working on a device that provides a more versatile alternative for your basic stethoscope used by general practitioners...

NADMED Oy is a Finnish health tech startup with an eye for NAD molecules. Outside of medicine, not many people know NAD, even though it is a molecule enabling or regulating hundreds of redox and metabolic reactions in the body. In addition, it is...

First patient cases always mark a major milestone for a medical device company in the development of novel treatments and devices. Health Incubator Helsinki startup EpiHeart reached this milestone in August 2022 when the first patient was treated...

The BioInnovation Institute has selected three international startup companies for its programme, one being Health Incubator Helsinki startup VEIL.AI. The €1.3M funding will support further development of VEIL.AI’s cutting-edge health data...

Karsa Oy is a spin-off company hailing from the University of Helsinki. Primarily, Karsa develops state-of-the-art instrumentation for molecular detection of explosives. However, the startup’s solutions can be used wherever ultra-sensitive and...

Moncyte R&D team has developed a unique solution that sheds light on why some people respond differently to cholesterol-lowering drugs. This novel, personalized test for optimal cholesterol-lowering therapy promises to open new ways for...